Vaccine

Serum Institute ties up with Bavarian Nordic to manufacture Mpox vaccine

Bavarian Nordic will transfer the technology of the current manufacturing process to SII to enable supply for the Indian market, the company said in a statement on Monday

Trump nominees should 'steer clear' of undermining polio vaccine: McConnell

Senate Republican leader Mitch McConnell, a childhood polio survivor, said any of President-elect Donald Trump's nominees seeking confirmation should steer clear of efforts to discredit the polio vaccine. Efforts to undermine public confidence in proven cures are not just uninformed they're dangerous, McConnell said in a Friday statement. Anyone seeking the Senate's consent to serve in the incoming Administration would do well to steer clear of even the appearance of association with such efforts. The 82-year-old lawmaker's statement appeared to be directed at Trump's nominee for health secretary, Robert F. Kennedy Jr., after a report that one of his advisors filed a petition to revoke approval for the polio vaccine in 2022. It was a sign that Kennedy, who has long advanced the debunked idea that vaccines cause autism, could face resistance in the soon-to-be GOP-controlled Senate. Mr. Kennedy believes the Polio Vaccine should be available to the public and thoroughly and properly .

Leading docs sign petition for suspension of all Covid-19 mRNA vaccines

Several doctors and healthcare professionals have signed a petition calling for the immediate suspension of all COVID-19 mRNA products because they fear the jabs could be contributing to an alarming rise in excess deaths. A petition known as the HOPE Accord attracting signatures from around the world went online recently to alert the international community on the continued use of the COVID mRNA vaccines. These vaccines, using gene-based technology, were given emergency use authorisation as one of the tools to address the coronavirus pandemic. A growing body of evidence suggests that the widespread rollout of the novel Covid-19 mRNA vaccine products is contributing to an alarming rise in disability and excess deaths, reads the Hope Accord petition. This new technology was granted emergency use authorisation to address a situation that no longer exists. Going forward, the burden of proof falls on those still advocating for these products to compellingly demonstrate that they aren't .

Abbott launches 14-valent pneumococcal vaccine in India for children

Pneumococcal vaccines address infections caused by pneumococcal bacteria, including pneumonia, meningitis, and blood infections, collectively known as invasive pneumococcal disease

India needs to expand local vaccine manufacturing, research: GTRI report

India needs to expand its local vaccine manufacturing and research to give better control over safety of these pharma products, think tank GTRI said on Monday. The Global Trade Research Initiative (GTRI) also suggested the government to launch an investigation to track all adverse health events post-vaccination as this could help make future vaccine rollouts more transparent, safe and effective. "Expanding local vaccine manufacturing and research can give India better control over vaccine safety, ensuring vaccines meet local needs and are tailored to the population's health characteristics," it said in a report. It added that these suggestions assume importance in the backdrop of the October 2024 release of "The Pfizer Papers: Crimes Against Humanity" which has ignited global debate over vaccine safety, ethics and transparency. "As the world prepares for future pandemics, the insights from The Pfizer Papers provide a foundation for building safer, more effective and more trustworth

WHO approves Zydus Lifesciences' typhoid vaccine for UN procurement

Typhoid affects an estimated 11 to 21 million people annually, leading to between 117,000 and 161,000 deaths

Dharma Productions-Adar Poonawalla deal gives quest for scale a chance

Biz of making films and shows needs more such tie-ups if it is to scale up

Study shows bacterial vaccine may serve as cancer immunotherapy treatment

The bacterial vaccine proved to be particularly more efficacious than peptide-based therapeutic cancer vaccines

CDSCO meets WHO standards for functional vaccine regulatory system

Drug regulator CDSCO and the National Regulatory Authority of India have met the standards set up by the World Health Organisation for a functional vaccine regulatory system A team of international experts from various countries led by the World Health Organisation (WHO) headquarters in Geneva reviewed India's vaccine regulatory system from September 16 to 20, the health ministry said in a statement. Safety, efficacy, and quality were the three basic parameters of assessment of vaccines, it said. The WHO has established global standards and benchmarks for assurance of vaccine quality through the development of tools and guidelines, benchmarking of the National Regulatory Authorities (NRA) and pre-qualification programme of vaccines, the statement said. The WHO NRA re-benchmarking was aimed to assess and document the status of the India regulatory system in the area of vaccine regulation, re-benchmark the status of the India vaccine regulatory system against the WHO NRA Global ...

US-India partnership to solve global challenges, advance growth: Official

India and the United States are working together to solve local and global problems, a senior American official said during her just-concluded trip to the South Asian country, according to a media release on Monday. Nisha Biswal, the US International Development Finance Corporation's (DFC) Deputy Chief Executive Officer, during her travel to Mumbai and New Delhi from September 10-14, highlighted the DFC's partnership with India to advance key growth and development priorities and work with the nation to solve the world's most critical challenges, the release said. While in India, Biswal announced USD 70 million in new DFC investments to support affordable home loans in India and vaccine manufacturing, it added. She spoke at the US-India Business Council's (USIBC) India Ideas Summit about the DFC's strategic vision for driving long-term growth between both countries and the broader Indo-Pacific region. She also spoke at a Milken Institute-hosted event that brought together US public

ICMR to advance 1st in-human trials for Zika, flu, blood cancer therapies

First-in-human trial is a type of clinical trial in which a new drug, procedure or treatment is tested in humans for the first time

WHO grants first mpox vaccine approval to enhance response in Africa

The World Health Organisation on Friday said it has granted its first authorisation for use of a vaccine against mpox in adults, calling it an important step toward fighting the disease in Africa and beyond. The pre-qualification of the vaccine by Bavarian Nordic A/S means that donors like GAVI the Vaccine Alliance and UNICEF can buy it. But supplies are limited because there's only a single manufacturer. This first pre-qualification of a vaccine against mpox is an important step in our fight against the disease, both in the context of the current outbreaks in Africa, and in future, said WHO Director-General Tedros Adhanom Ghebreyesus. The UN health agency chief called for urgent scale-up of procurement, donations and rollout to get the vaccine where it is needed most, along with other response measures. Under the WHO authorisation, the vaccine can be administered in people aged 18 or above in a two-dose regimen. The approval says that while the vaccine is not currently licensed fo

Africa's doses fall short amid Mpox spread while rich nations have plenty

A small fraction of those doses could help curb what is now the biggest mpox outbreak on record in the Democratic Republic of Congo and neighboring countries, disease experts say

DFC commits long-term loan of $20 mn to Panacea Biotec to expand operations

US International Development Finance Corporation (DFC) has committed a long-term loan of up to USD 20 million to Panacea Biotec, the company said on Thursday. Panacea is expanding the manufacturing capacity for drug substance antigens used in its hexavalent vaccine EasySix to meet future demand from UN agencies and public health organisations. DFC has agreed to provide a long-term loan of up to USD 20 million to the company to help finance this project, the biotechnology firm said in a regulatory filing. DFC's financing will enable Panacea Biotec to expedite the completion of the ongoing expansion and supply the hexavalent vaccine to UN agencies for childhood immunisation globally, it added. "Our hexavalent vaccine EasySix, which meets the highest standards of safety and efficacy, will have a meaningful impact on the lives of millions of newborns in the developing world," Panacea Biotec Chairman and MD Rajesh Jain said. DFC Deputy CEO Nisha Biswal said the organisation's partnersh

Canada to donate 'up to 200,000' doses of mpox vaccine: Govt official

Canada would not say to whom it would deliver the vaccines, or in what time frame

One Bavarian Nordic smallpox shot 58% effective against Mpox, shows study

One vaccination provided about 58 per cent protection against Mpox infection, researchers found in the study

Bharat Biotech, Alopexx partner to develop new broad-spectrum vaccine

Bharat Biotech, based in Genome Valley, Hyderabad, has a portfolio of vaccines and bio-therapeutics, including COVID-19 vaccines and novel vaccines for various infectious diseases

Bharat Biotech partners with Alopexx to develop anti-microbial vaccine

Bharat Biotech on Wednesday announced a collaboration with Alopexx Inc for development and commercialisation of the latter's broad-spectrum anti-microbial vaccine in India and other low income countries. As part of the collaboration, the companies will co-develop and commercialise the vaccine -- AV0328, in India and other licensed territories, Bharat Biotech said in a statement. Alopexx would be entitled to a one-time upfront payment and milestone payments, as well as royalties on future sales of AV0328 in the licensed territories, it added. "Our goal is to develop solutions to reduce anti-microbial resistance through vaccination. This collaboration aligns with our mission to provide safe, affordable, and high-quality vaccines to combat infectious diseases globally," Bharat Biotech Executive Chairman Krishna Ella said. Alopexx CEO Daniel Vlock said, this collaboration brings the company one step closer to addressing the critical need for affordable, broad-spectrum antimicrobial ..

Higher price of mpox vaccine to pose key hurdle in Africa order talks

But with a shot significantly pricier than many other vaccines commonly used for immunisation in Africa, costs remain a key barrier to getting more orders in place

FAME-III likely to see vehicles sporting government subsidy branding

Move aims to highlight Centre's electric mobility schemes and ensure greater transparency